EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proven anti-virulence therapies in combating methicillin- and vancomycin-resistant Staphylococcus aureus infections

Walid Bakeer, Marwa Gaafar, Ahmed O El-Gendy, Mohamed A El Badry, Mona G Khalil, Abdallah Tageldein Mansour, Nada K Alharbi, Heba M R M Selim, Mahmoud M Bendary

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1403219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Walid Bakeer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Staphylococcal Infections, Microbial Sensitivity Tests. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite years of efforts to develop new antibiotics for eradicating multidrug-resistant (MDR) and multi-virulent Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Staphylococcus aureus (VRSA) infections, treatment failures and poor prognoses in most cases have been common. Therefore, there is an urgent need for new therapeutic approaches targeting virulence arrays. Our aim is to discover new anti-virulence therapies targeting MRSA and VRSA virulence arrays. Methodology We employed phenotypic, molecular docking, and genetic studies to screen for anti-virulence activities among selected promising compounds: Coumarin, Simvastatin, and Ibuprofen.

Results

We found that nearly all detected MRSA and VRSA strains exhibited MDR and multi-virulent profiles. The molecular docking results aligned with the phenotypic and genetic assessments of virulence production. Biofilm and hemolysin productions were inhibited, and all virulence genes were downregulated upon treatment with sub-minimum inhibitory concentration (sub-MIC) of these promising compounds. Ibuprofen was the most active compound, exhibiting the highest inhibition and downregulation of virulence gene products. Moreover, in vivo and histopathological studies confirmed these results. Interestingly, we observed a significant decrease in wound area and improvements in re-epithelialization and tissue organization in the Ibuprofen and antimicrobial treated group compared with the group treated with antimicrobial alone. These findings support the idea that a combination of Ibuprofen and antimicrobial drugs may offer a promising new therapy for MRSA and VRSA infections.

Conclusion

We hope that our findings can be implemented in clinical practice to assist physicians in making the most suitable treatment decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsStaphylococcal InfectionsMicrobial Sensitivity TestsBiofilmsVirulence FactorsVancomycin-Resistant Staphylococcus aureusMolecular Docking SimulationAnimalsVirulenceIbuprofenHumansCoumarinsMiceDisease Models, AnimalHemolysin ProteinsDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

anti-virulencecoumarinhistopathologicalibuprofenmolecular dockingsimvastatin

Substanzen

Anti-Bacterial AgentsVirulence FactorsIbuprofenCoumarinsHemolysin Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
  • Quality Control Specialist at Egyptian Drug Authority (EDA), Cairo, Egypt.
  • Department of Botany and Microbiology, Faculty of Sciences, Al- Azhar University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt.
  • Department of Fish and Animal Production and Aquaculture, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa, Saudi Arabia.
  • Department of Fish and Animal Production, Faculty of Agriculture (Saba Basha), Alexandria University, Alexandria, Egypt.

Zitieren

APA

Bakeer, W., Gaafar, M., El-Gendy, A. O., El Badry, M. A., Khalil, M. G., Mansour, A. T., Alharbi, N. K., Selim, H. M. R. M., & Bendary, M. M. (2024). Proven anti-virulence therapies in combating methicillin- and vancomycin-resistant Staphylococcus aureus infections. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1403219

Vancouver

Bakeer W, Gaafar M, El-Gendy AO, El Badry MA, Khalil MG, Mansour AT, et al. Proven anti-virulence therapies in combating methicillin- and vancomycin-resistant Staphylococcus aureus infections. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1403219

BibTeX
@article{Bakeer2024,
  author = {Bakeer, Walid and Gaafar, Marwa and El-Gendy, Ahmed O and El Badry, Mohamed A and Khalil, Mona G and Mansour, Abdallah Tageldein and Alharbi, Nada K and Selim, Heba M R M and Bendary, Mahmoud M},
  title = {Proven anti-virulence therapies in combating methicillin- and vancomycin-resistant Staphylococcus aureus infections},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1403219}
}
Kostenlos starten →